PTC Therapeutics Inc.

PTC Therapeutics Inc.

World Rank (Jan-05-2024)
5,486
Market Cap (Jan-05-2024)
2.120 Billion USD
World Rank (Jul-30-2023)
4,320
Market Cap (Jul-30-2023)
3.037 Billion USD
World Rank (Jan-07-2022)
5,237
Market Cap (Jan-07-2022)
2.694 Billion USD
World Rank (Jan-01-2021)
3,400
Market Cap (Jan-01-2021)
4.164 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PTCT
Market Cap (Mar-08-2026)
5.20
Employee Count
1,177
Employee Count as of Date
As on 2021
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
698 Million USD
Annual Operating Income in USD
-439 Million USD
Annual Net Income in USD
-559 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,705 Million USD
Total Liabilities in USD
2,052 Million USD
Total Equity in USD
-347 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
HealthCare Products
Biotechnology
Biopharmaceutical
Company Website
PTC THERAPEUTICS INC
Yahoo
Yahoo @ Nasdaq
Company Profile

PTC Therapeutics is a Commercial and Diversified Biopharmaceutical company. It operates offices and research labs in more than 20 countries and occupy a business footprint in more than 50 countries around the world. It is a having 2,20,000 square feet in Hopewell, New Jersey. The headquarters is in USA.

Annual Results Summary

PTC THERAPEUTICS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022698-439 (Loss)-559 (Loss)
Dec-2021538-374 (Loss)-523 (Loss)
Dec-2020380-397 (Loss)-438 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,705 Million USD.

Total Liabilities as on Dec-2022 was 2,052 Million USD.

Total Equity as on Dec-2022 was -347 Million USD.

Founded Year
1998
IPO Year
2013
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share